Decipher Biosciences, Inc. is a San Diego-based company specializing in genomic testing for prostate and bladder cancer patients. Their flagship product, Decipher Prostate, utilizes genomic classification to stratify patients based on their risk of cancer progression, aiding physicians in treatment planning and decision-making. With extensive validation in numerous studies and over 60,000 patients, Decipher Prostate provides clarity and confidence in managing prostate cancer. Additionally, Decipher Bladder offers molecular subtyping for patients with bladder cancer, helping identify those at high risk of upstaging and determining the potential benefits of neoadjuvant chemotherapy. Decipher Biosciences is committed to empowering patients and physicians with accurate risk stratification and optimized therapy options.
Generated from the website